Half-year report · HY
4578.TEDINET S100YTLB
Period2026-01-01 → 2026-06-30
Filed2026-07-31
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.33T | 2026-01-01 → 2026-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥2.47T | 2025-01-01 → 2025-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.18T | 2025-01-01 → 2025-06-30 | Cons. | Revenue IFRS |
| Operating income | ¥278.5bn | 2026-01-01 → 2026-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥242.1bn | 2025-01-01 → 2025-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥285.4bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥468.0bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥226.3bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥215.6bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥363.1bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥173.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥218.5bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥175.9bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥4.40T | at 2026-06-30 | Cons. | Assets IFRS |
| Total assets | ¥4.20T | at 2025-12-31 | Cons. | Assets IFRS |
| Total assets | ¥3.79T | at 2025-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥1.09T | at 2026-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥1.10T | at 2025-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥3.31T | at 2026-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥3.10T | at 2025-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.79T | at 2025-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.78T | at 2024-12-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥3.24T | at 2026-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥3.03T | at 2025-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.72T | at 2025-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥469.5bn | at 2026-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥534.6bn | at 2025-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥411.1bn | at 2025-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥426.2bn | at 2024-12-31v | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥217.1bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥403.6bn | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥212.7bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥173.0bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥161.6bn | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥130.9bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥114.3bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥137.3bn | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥85.4bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥409.07 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥685.06 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥326.12 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share IFRS |
| Equity ratio | 73.7% | at 2026-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 72.3% | at 2025-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 71.8% | at 2025-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2026-01-01 → 2026-06-30 | ¥65.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2026-01-01 → 2026-06-30 | ¥63.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥1.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2026-01-01 → 2026-06-30 | ¥6.2bn |
| Reconciling Itemsreconciling | revenue | 2026-01-01 → 2026-06-30 | −¥1.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2026-01-01 → 2026-06-30 | −¥1.8bn |
| Reconciling Itemsreconciling | segment profit | 2026-01-01 → 2026-06-30 | −¥28.7bn |
| Consumer Productsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥17.5bn |
| Consumer Productsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥17.4bn |
| Consumer Productsreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥15m |
| Consumer Productsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥13.8bn |
| Nutraceuticalsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥300.1bn |
| Nutraceuticalsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥300.1bn |
| Nutraceuticalsreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥16m |
| Nutraceuticalsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥36.8bn |
| Pharmaceuticalsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥951.6bn |
| Pharmaceuticalsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥951.6bn |
| Pharmaceuticalsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥250.4bn |
| —segment total | revenue | 2026-01-01 → 2026-06-30 | ¥1.33T |
| —segment total | revenue external | 2026-01-01 → 2026-06-30 | ¥1.33T |
| —segment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥1.8bn |
| —segment total | segment profit | 2026-01-01 → 2026-06-30 | ¥307.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-01-01 → 2025-06-30 | ¥56.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-01-01 → 2025-06-30 | ¥55.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-01-01 → 2025-06-30 | ¥5.0bn |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥27.8bn |
| Consumer Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥15.8bn |
| Consumer Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥15.8bn |
| Consumer Productsreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥9m |
| Consumer Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥12.9bn |
| Nutraceuticalsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥276.1bn |
| Nutraceuticalsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥276.0bn |
| Nutraceuticalsreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥19m |
| Nutraceuticalsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥36.7bn |
| Pharmaceuticalsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥833.8bn |
| Pharmaceuticalsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥833.8bn |
| Pharmaceuticalsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥215.4bn |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥1.18T |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥1.18T |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1.7bn |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥269.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 797
| Item | Context | Value | Unit |
|---|---|---|---|
| Equity IFRS | InterimInstant | 3306756000000 | JPY |
| Profit loss before tax IFRS | Prior1InterimDuration | 226343000000 | JPY |
| Profit loss before tax IFRS | InterimDuration | 285420000000 | JPY |
| Depreciation and amortization ope cf IFRS | Prior1InterimDuration | 55158000000 | JPY |
| Depreciation and amortization ope cf IFRS | InterimDuration | 61476000000 | JPY |
| Impairment losses reversal of impairment losses ope cf IFRS | Prior1InterimDuration | 531000000 | JPY |
| Impairment losses reversal of impairment losses ope cf IFRS | InterimDuration | 4052000000 | JPY |
| Share of loss profit of investments accounted for using equity method ope cf IFRS | Prior1InterimDuration | -18760000000 | JPY |
| Share of loss profit of investments accounted for using equity method ope cf IFRS | InterimDuration | -20207000000 | JPY |
| Finance income ope cf IFRS | Prior1InterimDuration | -7702000000 | JPY |
| Finance income ope cf IFRS | InterimDuration | -11634000000 | JPY |
| Finance costs ope cf IFRS | Prior1InterimDuration | 23477000000 | JPY |
| Finance costs ope cf IFRS | InterimDuration | 4758000000 | JPY |
| Decrease increase in inventories ope cf IFRS | Prior1InterimDuration | -43516000000 | JPY |
| Decrease increase in inventories ope cf IFRS | InterimDuration | -34917000000 | JPY |
| Decrease increase in trade and other receivables2 ope cf IFRS | Prior1InterimDuration | -6854000000 | JPY |
| Decrease increase in trade and other receivables2 ope cf IFRS | InterimDuration | -11615000000 | JPY |
| Increase decrease in trade and other payables2 ope cf IFRS | Prior1InterimDuration | 13583000000 | JPY |
| Increase decrease in trade and other payables2 ope cf IFRS | InterimDuration | -14151000000 | JPY |
| Other changes in working capital ope cf IFRS | Prior1InterimDuration | -4269000000 | JPY |
| Other changes in working capital ope cf IFRS | InterimDuration | -4526000000 | JPY |
| Subtotal ope cf IFRS | Prior1InterimDuration | 237992000000 | JPY |
| Subtotal ope cf IFRS | InterimDuration | 258655000000 | JPY |
| Interest and dividends received ope cf IFRS | Prior1InterimDuration | 6592000000 | JPY |
| Interest and dividends received ope cf IFRS | InterimDuration | 9038000000 | JPY |
| Interest paid ope cf IFRS | Prior1InterimDuration | -2115000000 | JPY |
| Interest paid ope cf IFRS | InterimDuration | -2221000000 | JPY |
| Income taxes refund paid ope cf IFRS | Prior1InterimDuration | -29743000000 | JPY |
| Income taxes refund paid ope cf IFRS | InterimDuration | -48366000000 | JPY |
| Net cash provided by used in operating activities IFRS | Prior1InterimDuration | 212725000000 | JPY |
| Net cash provided by used in operating activities IFRS | InterimDuration | 217107000000 | JPY |
| Proceeds from sale of property plant and equipment inv cf IFRS | Prior1InterimDuration | 174000000 | JPY |
| Proceeds from sale of property plant and equipment inv cf IFRS | InterimDuration | 3014000000 | JPY |
| Purchase of property plant and equipment inv cf IFRS | Prior1InterimDuration | -45667000000 | JPY |
| Purchase of property plant and equipment inv cf IFRS | InterimDuration | -44938000000 | JPY |
| Purchase of intangible assets inv cf IFRS | Prior1InterimDuration | -11644000000 | JPY |
| Purchase of intangible assets inv cf IFRS | InterimDuration | -129268000000 | JPY |
| Proceeds from sale of investments inv cf IFRS | Prior1InterimDuration | 11447000000 | JPY |
| Proceeds from sale of investments inv cf IFRS | InterimDuration | 5443000000 | JPY |
| Purchase of investments inv cf IFRS | Prior1InterimDuration | -4123000000 | JPY |
| Purchase of investments inv cf IFRS | InterimDuration | -7674000000 | JPY |
| Payments for acquisition of subsidiaries inv cf IFRS | Prior1InterimDuration | -86625000000 | JPY |
| Payments for acquisition of subsidiaries inv cf IFRS | InterimDuration | -0 | JPY |
| Net decrease increase in time deposits inv cf IFRS | Prior1InterimDuration | 5300000000 | JPY |
| Net decrease increase in time deposits inv cf IFRS | InterimDuration | 673000000 | JPY |
| Other inv cf IFRS | Prior1InterimDuration | 195000000 | JPY |
| Other inv cf IFRS | InterimDuration | -256000000 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1InterimDuration | -130943000000 | JPY |
| Net cash provided by used in investing activities IFRS | InterimDuration | -173007000000 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | Prior1InterimDuration | -70096000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |